# Cerebral small vessel disease

Condition · id `cardio:cerebral-small-vessel-disease` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: CSVD; Cerebral small vessel diseases

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

Cerebral small vessel disease (CSVD) is damage to the small arteries and arterioles of the brain. It is often linked with ageing and high blood pressure. A 2026 open-access review calls it a major cause of ischemic stroke and of problems with thinking, and says it can also bring gait problems and neuropsychiatric symptoms that often go unrecognised. On brain imaging it is associated with white matter hyperintensities, lacunar infarcts and cerebral microbleeds. One review says it is not systematically screened for and is often undiagnosed. The reviews say treatment is limited to controlling risk factors, mainly blood pressure, and that the best blood pressure targets and medicines are not yet well defined.

## Technical summary

MeSH descriptor D059345 (Cerebral Small Vessel Diseases). Its scope note describes pathological processes in which cerebral microvessels show abnormalities, often associated with aging, hypertension and risk factors for lacunar infarcts, leukoaraiosis and cerebral hemorrhage. A 2026 open-access review calls it a clinico-radiological syndrome that covers imaging and histopathological findings, links its imaging features to the two most prevalent mechanisms, arteriosclerosis and cerebral amyloid angiopathy, names age and hypertension as key risk factors, and says treatment remains limited to risk factor control. A 2025 open-access review of hypertension and small vessel disease says chronic hypertension often leads to it, that it often presents with cognitive dysfunction, gait abnormalities and an elevated risk of stroke, and that the primary management strategy is stringent control of blood pressure while the precise targets and preferred antihypertensive medicines are not well defined. The text rests on the MeSH scope note and those two reviews; it gives no targets, doses or advice.

## Connected pages

- Filed under this front: Prevention and lifestyle (`cardio:front-prevention-and-lifestyle`)
- Related condition: Hypertension (high blood pressure) (`core:hypertension`)
- Related condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Related condition: Stroke (`core:stroke`)
- Related condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 19 registry trials

## Provenance

Content hash: d9470e7ec7b52a9fc7a015ac6491decac3b72a9519b5cae2ba5f54715d68e5b0
Last substantive edit: 2026-11-09
Evidence last checked: 2026-11-09
